The NEA established the High-level Group on the Security of Supply of Medical Radioisotopes (HLG-MR) in April 2009 to examine the underlying reasons for the global 2009-10 supply shortage and to develop a policy approach to ensure the long-term security of supply of molybdenum-99 (99Mo) and technetium-99m (99mTc). To achieve its objectives, the HLG-MR reviewed the 99Mo/99mTc supply chain and identified the key areas of vulnerability, the issues that need to be addressed and proposed mechanisms that could be used to address those issues. The HLG-MR agreed on a policy approach to ensure the long-term reliability of supply, but recognised that governments have the ultimate responsibility for establishing an environment conducive to investment and for regulations related to the 99Mo/99mTc supply chain.
In 2014, a "Joint Declaration on the Security of Supply of Medical Radioisotopes" was agreed and published by a number of NEA countries.
The HLG-MR mandates were performed during the following periods:
Last reviewed: 25 March 2019